medigraphic.com
ISSN 1684-1824 (Electronic)

2021, Number 3

<< Back Next >>

Rev Méd Electrón 2021; 43 (3)

Community Clostridium difficile infection associated to idiopathic ulcerative colitis

Hernández OA, Sánchez CJC, Umpiérrez GI, Sánchez HRC

Language: Spanish
References: 27
Page: 855-867
PDF size: 11320.12 Kb.


ABSTRACT

Clostridium difficile is a bacterium related to antibiotic-associated colitis and to diarrhea acquired in hospitalized patients. However, its behavior has changed in recent years to the point of being considered as a global health problem. Its clinical course ranges from asymptomatic cases, colitis, to complications with risk for the patient’s life. The inflammatory bowel disease, especially idiopathic ulcerative colitis is found among the described risk factors. The case reported deals with the presentation of this infection associated to an outbreak of ulcerative colitis in a young patient, with no previous history of inflammatory bowel disease, consumption of antibiotics or hospitalization.


REFERENCES

  1. Álvarez Hernández DA, González Chávez AM, González Hermosillo CD, et al. Perspectivas históricas y vigentes sobre la infección por Clostridium difficile. Rev Gastroenterol Mex. 2018 [citado 19/03/2020];83(1):41-50. Disponible en: Disponible en: https://doi.org/10.1016/j.rgmx.2017.03.004

  2. Paciel D, Medina JC. Clostridium difficile: historia de una infección emergente y su manejo actual. An Facultad Med [Internet]. 2015 [citado 19/03/2020];2(1):87-95. Disponible en: Disponible en: http://www.anfamed.edu.uy/index.php/rev/article/view/144

  3. Abreu y Abreu AT, Velarde-Ruiz Velasco JA, Zavala-Solares MR, et al. Consenso sobre prevención, diagnóstico y tratamiento de la infección por Clostridium difficile. Rev Gastroenterol Mex . 2019 [citado 19/03/2020];84(2):204-19. Disponible en: Disponible en: https://doi.org/10.1016/j.rgmx.2018.12.001

  4. Alcalá Hernández L, Reigadas Ramírez E, Bouza Santiago E. Infección por Clostridium difficile. Medicina Clínica. 2017 [citado 19/03/2020];148(10):456-63. Disponible en: Disponible en: https://doi:10.1016/j.medcli.2017.01.033

  5. Carvajal C, Pacheco C, Jaimes F. Perfil clínico y demográfico y factores de riesgo frente a laInfección por Clostridium difficile. Biomédica [Internet]. 2017 Ene [citado 17/05/2021];37(1):53-61. Disponible en: Disponible en: https://doi.org/10.7705/biomedica.v37i1.2915

  6. Schäffler H, Breitrück A. Clostridium difficile - From Colonization to Infection. Microbiol. 2018;9:646. Citado en PubMed; PMID: 29692762.

  7. Chandrasekaran R, Lacy DB. The role of toxins in Clostridium difficile infection. FEMS Microbiol Rev. 2017;41(6):723-50. Citado en PubMed; PMID: 29048477.

  8. Lamont TJ, Kelly CP, Bakken JS. Clostridioides (formerly Clostridium) difficile infection in adults: Clinical manifestations and diagnosis [Internet]. Países Bajos: UpToDate; 2021 [citado 19/03/2021]. Disponible en: Disponible en: https://www.uptodate.com/contents/clostridioides-formerly-clostridium-difficile-infection-in-adults-clinical-manifestations-and-diagnosis/print

  9. MacDermott S. Management of Mild-to-Moderate Ulcerative Colitis. Dig Dis. 2015;33(Suppl.1):90-4. Citado en PubMed; PMID: 26368795.

  10. Falces Romero I, Troyano Hernáez P, García Bujalance S, et al. Detección de Clostridium difficile toxigénico en pediatría. Enferm Infecc y Microbiol Clín. 2018;36(6):357-61. DOI: 10.1016/j.eimc.2017.05.006.

  11. Snapper SB, Abraham C. Immune and microbial mechanisms in the pathogenesis of inflammatory bowel disease [Internet]. Países Bajos: UpToDate ; 2021 [citado 19/03/2021]. Disponible en: Disponible en: https://www.uptodate.com/contents/immune-and-microbial-mechanisms-in-the-pathogenesis-of-inflammatory-bowel-disease/print

  12. American Society for Gastrointestinal Endoscopy Standards of Practice Committee, Shergill AK, Lightdale JR, et al. The role of endoscopy in inflammatory bowel disease. Gastrointest Endosc. 2015;81(5):1101-21. Citado en PubMed; PMID: 25800660.

  13. Subramanian V, Chatu S, Echterdiek F, et al. Patients with Endoscopically Visible Polypoid Adenomatous Lesions Within the Extent of Ulcerative Colitis Have an Increased Risk of Colorectal Cancer Despite Endoscopic Resection. Dig Dis Sci. 2016;61(10):3031-6. Citado en PubMed; PMID: 27405991.

  14. Ofosu A. Clostridium difficile infection: A review of current and emerging therapies. Ann Gastroenterol. 2016;29:147-54. Citado en PubMed; PMID: 27065726.

  15. Barra Carrasco J, Hernández Rocha C, Ibáñez P, et al. Esporas de Clostridium difficile y su relevancia en la persistencia y transmisión de la infección. Rev Chil infectol [Internet]. 2014 [citado 19/03/2020];31:694-703. Disponible en: Disponible en: http://dx.doi.org/10.4067/s0716-10182014000600010

  16. Dae Bum K, Kang Moon L. Is Clostridium difficile infection a real threat in patients with ulcerative colitis? Intest Res [Internet]. 2018 [citado 19/03/2020];16(2):267-72. Disponible en: Disponible en: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5934599/

  17. Alcalá Hernández L , Mena Ribas A, Niubó Bosh J, et al. Diagnóstico microbiológico de laInfección por Clostridium difficile. Enferm Infecc Microbiol Clin. 2016 [citado 19/03/2020];34(9):595-602. DOI: 10.1016/j.eimc.2015.09.004.

  18. García García de Paredes A, Rodríguez de Santiago E, Aguilera Castro L, et al. Transplante de microbiota fecal. Gastroenterol Hepatol [Internet]. 2015 [citado 19/03/2020];38(3):123-34. Disponible en: Disponible en: https://doi.org/10.1016/j.gastrohep.2014.07.010

  19. Ramos Martínez A, Ortiz Balbuena J, Curto García I, et al. Factores de riesgo de diarrea por Clostridium difficile en pacientes con enfermedad inflamatoria intestinal. Rev esp enferm dig [Internet]. 2015 [citado 19/03/2020];107(1):4-9. Disponible en: Disponible en: https://www.scielo.isciii.es/scielo.php?pid=S1130-01082015000100002&script=_arttext&tlng=es

  20. Binion D. Clostridium difficile Infection and Inflammatory Bowel Disease. Gastroenterol Hepatol [Internet]. 2016 [citado 19/03/2020];12(5):334-7. Citado en PubMed; PMID: 27499718.

  21. Kaneko T, Matsuda R, Taguri M, et al. Clostridium difficile infection in patients with ulcerative colitis: investigations of risk factors and efficacy of antibiotics for steroid refractory patients. Clin Res Hepatol Gastroenterol. 2011;35(4):315-20. Citado en PubMed; PMID: 21435967.

  22. Berg AM, Kelly CP, Farraye FA. Clostridium difficile infection in the inflammatory bowel disease patient. Inflamm Bowel Dis. 2013;19(1):194-204. Citado en PubMed; PMID: 22508484.

  23. Negrón ME, Rezaie A, Barkema HW, et al. Ulcerative Colitis Patients with Clostridium difficile are at Increased Risk of Death, Colectomy, and Postoperative Complications: A Population-Based Inception Cohort Study. Am J Gastroenterol. 2016;111(5):691-704. Citado en PubMed; PMID: 27091322.

  24. Evans CT, Safdar N. Current Trends in the Epidemiology and Outcomes of Clostridium difficile Infection. Clin Infect Dis. 2015;60(Suppl. 2):66-71. Citado en PubMed; PMID: 25922403.

  25. Seekatz AM, Vincent B. Clostridium difficile and the microbiota. Clin Invest. 2014;124(10):4182-9. Citado en PubMed; PMID: 25036699.

  26. Oñate Gutiérrez JM, Segura J, Correa A, et al. Infección por Clostridium difficile: descripción de las cepas NAP1/027 y de otros serotipos en un centro de alta complejidad de Cali, Colombia. Biomédica [Internet]. 2019 [citado 19/03/2020];39(Supl.1):63-70. Disponible en: Disponible en: https://revistabiomedica.org/index.php/biomedica/article/view/3950/4315

  27. Ben-Horin S, Margalit M, Bossuyt P, et al. Prevalence and clinical impact of endoscopic pseudomembranes in patients with inflammatory bowel disease and Clostridium difficile infection. J Crohns Colitis. 2010;4(2):194-8. Citado en PubMed; PMID: 21122505.




2020     |     www.medigraphic.com